CG
TEVA icon

Cutler Group’s Teva Pharmaceuticals TEVA Stock Holding History

Cutler Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-5,500
Closed -$3K – 4703
2022
Q4 		$3K Sell
5,500
-22,600
-80% -$197K ﹤0.01% 3541
2022
Q3 		$46K Sell
28,100
-42,900
-60% -$379K ﹤0.01% 1953
2022
Q2 		$106K Sell
71,000
-47,900
-40% -$417K 0.01% 1419
2022
Q1 		$51K Buy
+118,900
New +$992K ﹤0.01% 2235
2021
Q1 		– Sell
-15,000
Closed -$8K – 6274
2020
Q4 		$8K Hold
15,000
– – ﹤0.01% 3368
2020
Q3 		$24K Hold
15,000
– – ﹤0.01% 2335
2020
Q2 		$14K Sell
15,000
-11,300
-43% -$128K ﹤0.01% 2643
2020
Q1 		$63K Buy
26,300
+9,300
+55% +$95.3K ﹤0.01% 1591
2019
Q4 		$52K Hold
17,000
– – ﹤0.01% 1604
2019
Q3 		$90K Hold
17,000
– – 0.01% 1133
2019
Q2 		$64K Buy
17,000
+15,000
+750% +$181K 0.01% 1369
2019
Q1 		$9K Sell
2,000
-2,100
-51% -$37K ﹤0.01% 2579
2018
Q4 		$13K Hold
4,100
– – ﹤0.01% 2395
2018
Q3 		$7K Buy
+4,100
New +$95.2K ﹤0.01% 2880
2018
Q2 		– Sell
-100
Closed -$1K – 4879
2018
Q1 		$1K Sell
100
-57,700
-100% -$1.13M ﹤0.01% 4165
2017
Q4 		$340K Sell
57,800
-23,800
-29% -$358K 0.01% 701
2017
Q3 		$685K Buy
81,600
+4,600
+6% +$104K 0.03% 500
2017
Q2 		$118K Sell
77,000
-94,000
-55% -$2.91M ﹤0.01% 1725
2017
Q1 		$1.68M Buy
171,000
+35,800
+26% +$1.22M 0.07% 234
2016
Q4 		$990K Buy
135,200
+102,400
+312% +$4.09M 0.04% 414
2016
Q3 		$135K Buy
32,800
+22,700
+225% +$1.18M 0.01% 1560
2016
Q2 		$25K Sell
10,100
-100
-1% -$5.32K ﹤0.01% 3123
2016
Q1 		$72K Sell
10,200
-49,300
-83% -$2.89M ﹤0.01% 1945
2015
Q4 		$51K Buy
+59,500
New +$3.68M ﹤0.01% 2440

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Cutler Group's TEVA Position: Q1 2024 in Review

Cutler Group sold out of Teva Pharmaceuticals (TEVA) in Q1 2024, closing a stake of 1,900 shares — an estimated $19K sold.

Cutler Group first reported a position in TEVA in Q4 2015 and held it in 28 quarters. The position peaked at $4.65M in Q1 2017. 481 funds tracked by Wall St. Rank hold TEVA as of Q1 2024.

  • Cutler Group reported no remaining Teva Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Cutler Group sold 1,900 Teva Pharmaceuticals shares in Q1 2024, an estimated $19K.
  • Cutler Group first reported a position in Teva Pharmaceuticals in Q4 2015 and held it in 28 quarters.
  • Cutler Group's Teva Pharmaceuticals position peaked at $4.65M in Q1 2017.
  • 481 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.